Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial
Addiction · 2025-11 · 120 (11) · 2231-2244
DOI: 10.1111/add.70097 ↗At a glance
Randomisierte kontrollierte Studie in Addiction, published online on 2025-05-29. Written by Sera Lortye and 7 co-authors. Institution: Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands. Major MEDLINE topics: Stress Disorders, Post-Traumatic, Eye Movement Desensitization Reprocessing, Substance-Related Disorders, Implosive Therapy. Cited 6 times so far (Crossref); 38 references. Funded by: Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes-en Zenuwziekten.
Topics: Sucht und Abhängigkeit
Abstract (original language)
Background and aims Post‐traumatic stress disorder (PTSD) and substance use disorder (SUD) are highly co‐occurring and evidence for the optimal ways of treating PTSD in SUD patients is mixed. Our aim was to compare three different PTSD treatments, each added simultaneously to SUD treatment, with SUD treatment alone in patients with co‐occurring SUD‐PTSD. These PTSD treatments were: Prolonged Exposure (PE), Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs).
Design
A single‐blind 4‐arm randomized controlled trial with follow‐up at 3 months.
Setting
Two addiction treatment centers in the Netherlands, providing intra‐ and extramural care.
Participants
209 patients with SUD and co‐morbid PTSD were included [mean age 37.5 (standard deviation, SD = 11.99), female sex = 46.4%, mean Clinically Administered PTSD Scale (CAPS) score = 37.35 (SD = 9.28)].
Interventions
Participants were randomized to either simultaneous SUD + PE ( n = 53), SUD + EMDR ( n = 50), SUD + ImRs ( n = 55) or to SUD treatment only ( n = 51), with the active PTSD treatments consisting of 12 sessions each within 3 months. Standard protocols were used.
Measurements
The primary outcome was clinician‐administered PTSD symptom severity as measured by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (CAPS‐5) at 3 month follow‐up. Secondary outcomes included loss of PTSD diagnosis, full remission of PSTD and SUD‐severity, also recorded at 3 months.
Findings
Compared with SUD only, the mean differences in CAPS‐5 score were B = −5.41 [95% confidence interval (CI) = 10.88, 0.05, P = 0.052] for SUD + PE, B = −7.97 (95% CI = −13.57, −2.37, P = 0.006) for SUD + EMDR and B = −10.03 (95% CI = −15.29, −4.77, P < 0.001) for SUD + ImRs. When adjusted for baseline covariates, mean differences were B = −5.81 (95% CI = −11.48, −0.15, P = 0.044) for SUD + PE, B = ‐8.85 (95% CI = −14.60, −3.10, P = 0.003) for SUD + EMDR and B = ‐10.75 (95% CI = −15.94, −5.56, P =
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Arkin Mental Health Care, Jellinek, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands.
- Department of Research, Arkin Mental Health Care, Amsterdam, the Netherlands.
- Department of Psychiatry, University Medical Center (UMC) -University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
- Department of Clinical Psychology, University of Amsterdam, Amsterdam, the Netherlands.
ORCID profiles: Sera Lortye
Funding
- Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes-en Zenuwziekten
Cite
APA
Lortye, S., Will, J. P., Marquenie, L. A., Lommerse, N. M., Faber, N., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2025). Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction, 120(11), 2231-2244. https://doi.org/10.1111/add.70097
Vancouver
Lortye S, Will JP, Marquenie LA, Lommerse NM, Faber N, Goudriaan AE, et al. Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction. 2025;120(11):2231-2244. doi:10.1111/add.70097
BibTeX
@article{Lortye2025,
author = {Lortye, Sera and Will, Joanne P and Marquenie, Loes A and Lommerse, Nick M and Faber, Nathalie and Goudriaan, Anna E and Arntz, Arnoud and de Waal, Marleen M},
title = {Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial},
journal = {Addiction},
year = {2025},
volume = {120},
number = {11},
pages = {2231--2244},
doi = {10.1111/add.70097}
}
EUVIMED